KARYOPHARM THERAPEUTICS INC shareholders Q3 2023

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

KARYOPHARM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
JACOBS LEVY EQUITY MANAGEMENT, INC 2,353,528$3,153,7280.02%
ExodusPoint Capital Management, LP 1,397,543$1,8730.02%
State of Wyoming 40,741$54,5930.01%
Candriam S.C.A. 1,140,694$1,528,5300.01%
Headlands Technologies LLC 13,817$18,5150.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 289,500$387,9300.01%
MARSHALL WACE, LLP 2,183,201$2,925,4900.01%
J. Goldman & Co LP 120,000$160,8000.01%
Point72 Middle East FZE 95,138$127,4850.00%
Graham Capital Management, L.P. 82,309$110,2940.00%
BOOTHBAY FUND MANAGEMENT, LLC 81,736$109,5260.00%
EXCHANGE TRADED CONCEPTS, LLC 86,484$115,8890.00%
BNP PARIBAS FINANCIAL MARKETS 1,660,898$2,225,6030.00%
Woodline Partners LP 134,112$179,7100.00%
Founders Capital Management 2,000$2,6800.00%
WADE G W & INC 45,140$600.00%
Quantbot Technologies LP 21,699$29,0770.00%
Engineers Gate Manager LP 38,962$52,2090.00%
UBS OCONNOR LLC 300,000$60,0000.00%
Renaissance Technologies 730,400$9790.00%
External links

This page lists KARYOPHARM THERAPEUTICS INC's shareholders in Q3 2023. To view KARYOPHARM THERAPEUTICS INC's shareholder history, click here.